541 related articles for article (PubMed ID: 30876475)
1. Neutrophil-to-lymphocyte ratio and incident end-stage renal disease in Chinese patients with chronic kidney disease: results from the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE).
Yuan Q; Wang J; Peng Z; Zhou Q; Xiao X; Xie Y; Wang W; Huang L; Tang W; Sun D; Zhang L; Wang F; Zhao MH; Tao L; He K; Xu H;
J Transl Med; 2019 Mar; 17(1):86. PubMed ID: 30876475
[TBL] [Abstract][Full Text] [Related]
2. Urinary magnesium predicts risk of cardiovascular disease in Chronic Kidney Disease stage 1-4 patients.
Yuan Q; Xie Y; Peng Z; Wang J; Zhou Q; Xiao X; Wang W; Huang L; Tang W; Li X; Zhang L; Wang F; Zhao MH; Tao L; He K; Wanggou S; Xu H;
Clin Nutr; 2021 Apr; 40(4):2394-2400. PubMed ID: 33160701
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease (C-STRIDE).
Yuan J; Zou XR; Han SP; Cheng H; Wang L; Wang JW; Zhang LX; Zhao MH; Wang XQ;
BMC Nephrol; 2017 Jan; 18(1):23. PubMed ID: 28088175
[TBL] [Abstract][Full Text] [Related]
4. Association between Monocyte Count and Risk of Incident CKD and Progression to ESRD.
Bowe B; Xie Y; Xian H; Li T; Al-Aly Z
Clin J Am Soc Nephrol; 2017 Apr; 12(4):603-613. PubMed ID: 28348030
[TBL] [Abstract][Full Text] [Related]
5. Does neutrophyl to lymphocyte ratio really predict chronic kidney disease progression?
Altunoren O; Akkus G; Sezal DT; Ciftcioglu M; Guzel FB; Isiktas S; Torun GI; Uyan M; Sokmen MF; Sevim HA; Sarısık FN; Senel ME; Erken E; Gungor O
Int Urol Nephrol; 2019 Jan; 51(1):129-137. PubMed ID: 30276600
[TBL] [Abstract][Full Text] [Related]
6. Serum β-Trace Protein and β2-Microglobulin as Predictors of ESRD, Mortality, and Cardiovascular Disease in Adults With CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study.
Foster MC; Coresh J; Hsu CY; Xie D; Levey AS; Nelson RG; Eckfeldt JH; Vasan RS; Kimmel PL; Schelling J; Simonson M; Sondheimer JH; Anderson AH; Akkina S; Feldman HI; Kusek JW; Ojo AO; Inker LA;
Am J Kidney Dis; 2016 Jul; 68(1):68-76. PubMed ID: 26948990
[TBL] [Abstract][Full Text] [Related]
7. Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
Grams ME; Yang W; Rebholz CM; Wang X; Porter AC; Inker LA; Horwitz E; Sondheimer JH; Hamm LL; He J; Weir MR; Jaar BG; Shafi T; Appel LJ; Hsu CY;
Am J Kidney Dis; 2017 Sep; 70(3):337-346. PubMed ID: 28366517
[TBL] [Abstract][Full Text] [Related]
8. High neutrophil/lymphocyte ratio is associated with poor renal outcomes in Japanese patients with chronic kidney disease.
Yoshitomi R; Nakayama M; Sakoh T; Fukui A; Katafuchi E; Seki M; Tsuda S; Nakano T; Tsuruya K; Kitazono T
Ren Fail; 2019 Nov; 41(1):238-243. PubMed ID: 30942116
[TBL] [Abstract][Full Text] [Related]
9. Association of Serum Ig Free Light Chains with Mortality and ESRD among Patients with Nondialysis-Dependent CKD.
Ritchie J; Assi LK; Burmeister A; Hoefield R; Cockwell P; Kalra PA
Clin J Am Soc Nephrol; 2015 May; 10(5):740-9. PubMed ID: 25825483
[TBL] [Abstract][Full Text] [Related]
10. Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe.
Ryom L; Kirk O; Lundgren JD; Reiss P; Pedersen C; De Wit S; Buzunova S; Gasiorowski J; Gatell JM; Mocroft A;
HIV Med; 2013 Sep; 14(8):503-8. PubMed ID: 23590641
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil-to-lymphocyte ratio predicts long-term all-cause mortality in patients with chronic kidney disease stage 5.
Woziwodzka K; Dziewierz A; Pawica M; Panek A; Krzanowski M; Gołasa P; Latacz P; Burkat M; Kuźniewski M; Krzanowska K
Folia Med Cracov; 2019; 59(4):55-70. PubMed ID: 31904750
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of the neutrophil-to-lymphocyte ratio in patients with chronic kidney disease.
Kim J; Song SH; Oh TR; Suh SH; Choi HS; Kim CS; Ma SK; Kim SW; Bae EH
Korean J Intern Med; 2023 Sep; 38(5):725-733. PubMed ID: 37586809
[TBL] [Abstract][Full Text] [Related]
13. Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics.
Provenzano M; Chiodini P; Minutolo R; Zoccali C; Bellizzi V; Conte G; Locatelli F; Tripepi G; Del Vecchio L; Mallamaci F; Di Micco L; Russo D; Heerspink HJL; De Nicola L
Nephrol Dial Transplant; 2020 Jan; 35(1):138-147. PubMed ID: 30053127
[TBL] [Abstract][Full Text] [Related]
14. The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: An external validation and clinical impact projection cohort study.
Major RW; Shepherd D; Medcalf JF; Xu G; Gray LJ; Brunskill NJ
PLoS Med; 2019 Nov; 16(11):e1002955. PubMed ID: 31693662
[TBL] [Abstract][Full Text] [Related]
15. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
[TBL] [Abstract][Full Text] [Related]
16. Soluble urokinase-type plasminogen activator receptor and incident end-stage renal disease in Chinese patients with chronic kidney disease.
Lv L; Wang F; Wu L; Wang JW; Cui Z; Hayek SS; Wei C; Reiser J; He K; Zhang L; Chen M; Zhao MH
Nephrol Dial Transplant; 2020 Mar; 35(3):465-470. PubMed ID: 30124995
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum anion gap in adults with moderate chronic kidney disease increases risk for progression to end-stage renal disease.
Banerjee T; Crews DC; Wesson DE; McCulloch CE; Johansen KL; Saydah S; Rios Burrows N; Saran R; Gillespie B; Bragg-Gresham J; Powe NR
Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1244-F1253. PubMed ID: 30908932
[TBL] [Abstract][Full Text] [Related]
18. Serum uromodulin and progression of kidney disease in patients with chronic kidney disease.
Lv L; Wang J; Gao B; Wu L; Wang F; Cui Z; He K; Zhang L; Chen M; Zhao MH
J Transl Med; 2018 Nov; 16(1):316. PubMed ID: 30454063
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil-to-lymphocyte ratio and platelet-tolymphocyte ratio in evaluation of inflammation in end-stage renal disease.
Ahbap E; Sakaci T; Kara E; Sahutoglu T; Koc Y; Basturk T; Sevinc M; Akgol C; Kayalar AO; Ucar ZA; Bayraktar F; Unsal A
Clin Nephrol; 2016 Apr; 85(4):199-208. PubMed ID: 26521887
[TBL] [Abstract][Full Text] [Related]
20. Diabetes Control and the Risks of ESRD and Mortality in Patients With CKD.
Navaneethan SD; Schold JD; Jolly SE; Arrigain S; Winkelmayer WC; Nally JV
Am J Kidney Dis; 2017 Aug; 70(2):191-198. PubMed ID: 28196649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
